|
1
|
Picci P, Mercuri M, Ferrari S, et al:
Survival in high-grade osteosarcoma: Improvement over 21 years at a
single institution. Ann Oncol. 21:1366–1373. 2010. View Article : Google Scholar
|
|
2
|
Broadhead ML, Clark JC, Myers DE, Dass CR
and Choong PF: The molecular pathogenesis of osteosarcoma: A
review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cesari M, Alberghini M, Vanel D, et al:
Periosteal osteosarcoma: A single-institution experience. Cancer.
117:1731–1735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thomas DM: Wnts, bone and cancer. J
Pathol. 220:1–4. 2010. View Article : Google Scholar
|
|
5
|
Liu T, Zhou W, Zhang F, et al: Knockdown
of IRX2 inhibits osteosarcoma cell proliferation and invasion by
the AKT/MMP9 signaling pathway. Mol Med Rep. 10:169–174.
2014.PubMed/NCBI
|
|
6
|
Kadota M, Sato M, Duncan B, et al:
Identification of novel gene amplifications in breast cancer and
coexistence of gene amplification with an activating mutation of
PIK3CA. Cancer Res. 69:7357–7365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Adamowicz M, Radlwimmer B, Rieker RJ, et
al: Frequent amplifications and abundant expression of TRIO, NKD2
and IRX2 in soft tissue sarcomas. Genes Chromosomes Cancer.
45:829–838. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang H, Wilson CS, Harvey RC, et al: Gene
expression profiles predictive of outcome and age in infant acute
lymphoblastic leukemia: A Children's Oncology Group study. Blood.
119:1872–1881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sato T, Arai E, Kohno T, et al: Epigenetic
clustering of lung adenocarcinomas based on DNA methylation
profiles in adjacent lung tissue: Its correlation with smoking
history and chronic obstructive pulmonary disease. Int J Cancer.
135:319–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Francipane MG and Lagasse E: mTOR pathway
in colorectal cancer: An update. Oncotarget. 5:49–66.
2014.PubMed/NCBI
|
|
11
|
Pandurangan AK and Esa NM: Signal
transducer and activator of transcription 3-a promising target in
colitis-associated cancer. Asian Pac J Cancer Prev. 15:551–560.
2014. View Article : Google Scholar
|
|
12
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: an
updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo YS, Zhao R, Ma J, et al: βig-h3
promotes human osteosarcoma cells metastasis by interacting with
integrin alpha2beta1 and activating PI3K signaling pathway. PLoS
One. 9:e902202014. View Article : Google Scholar
|
|
15
|
Gong C, Liao H, Wang J, et al: LY294002
induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like
cells from human osteosarcoma via down-regulation of PI3K activity.
Asian Pac J Cancer Prev. 13:3103–3107. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang A, He S, Sun X, et al: Wnt5a
promotes migration of human osteosarcoma cells by triggering a
phosphatidylinositol-3 kinase/Akt signals. Cancer Cell Int.
14:152014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao H, Li M, Li L, et al: MiR-133b is
down-regulated in human osteosarcoma and inhibits osteosarcoma
cells proliferation, migration and invasion and promotes apoptosis.
PLoS One. 8:e835712013. View Article : Google Scholar
|
|
18
|
Kang J, Rychahou PG, Ishola TA, et al:
N-myc is a novel regulator of PI3K-mediated VEGF expression in
neuroblastoma. Oncogene. 27:3999–4007. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garcia V, Garcia JM, Silva J, et al:
Levels of VEGF-A mRNA in plasma from patients with colorectal
carcinoma as possible surrogate marker of angiogenesis. J Cancer
Res Clin Oncol. 134:1165–1171. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dillon RL and Muller WJ: Distinct
biological roles for the akt family in mammary tumor progression.
Cancer Res. 70:4260–4264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hassan B, Akcakanat A, Holder AM and
Meric-Bernstam F: Targeting the PI3-kinase/Akt/mTOR signaling
pathway. Surg Oncol Clin N Am. 22:641–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao CL, Lai KC, Huang AC, et al: Gallic
acid inhibits migration and invasion in human osteosarcoma U-2 OS
cells through suppressing the matrix metalloproteinase -2/-9,
protein kinase B (PKB) and PKC signaling pathways. Food Chem
Toxicol. 50:1734–1740. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu J, Wu X, Zhong D, et al: Short Hairpin
RNA (shRNA) Ether à go-go 1 (Eag1) inhibition of human osteosarcoma
angiogenesis via VEGF/PI3K/AKT signaling. Int J Mol Sci.
13:12573–12583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Maldegem AM, Bhosale A, Gelderblom HJ,
Hogendoorn PC and Hassan AB: Comprehensive analysis of published
phase I/II clinical trials between 1990–2010 in osteosarcoma and
Ewing sarcoma confirms limited outcomes and need for translational
investment. Clin Sarcoma Res. 2:52012. View Article : Google Scholar
|
|
25
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
